Loading provider…
Loading provider…
Neurology Physician in New York, NY
NPI: 1003994708Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Option Care
optioncarehealth.com
HQ Phone
Get MD Norman's Phone Numberphone_androidMobile
Get MD Norman's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2022
NY State Medical License
1979 - 2025

American Board of Psychiatry and Neurology
Neurology
New York Presbyterian Hospital (Columbia Campus)
Residency • Neurology
1976 - 1980
Boston University Medical Center
Internship • Internal Medicine
1975 - 1976
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1975
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 230 | 331 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 120 | 120 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 17 | 17 |
Anti‐MAG IgM antibodies in patients with neuropathy and IgM M proteins Detection by ELISA
Authors: Eduardo Nobile-Orazio, Tom Vietorisz, Mary Jo Messito, William H. Sherman, Norman Latov
Publication Date: 1983-07
Immune Cross-Reactivity in Celiac Disease: Anti-Gliadin Antibodies Bind to Neuronal Synapsin I
Authors: Peter Green
Journal: J Immunol
Human Monoclonal IgM Anti-Gal(β1-3)GaINAc Autoantibodies Bind to the Surface of Bovine Spinal Motoneurons
Authors: Florian P. Thomas, Jeffrey Thomas, Saud Sadiq, Leonard H. Van Den Berg, Robert I. Roelofs, Norman Latov, Arthur P. Hays
Publication Date: 1990-03
Lead Sponsor: Grifols Therapeutics LLC
Intervention / Treatment: DRUG: Albumin (Human) 25%, United States Pharmacopeia (USP), DRUG: Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified